GlassScriptPhysician profile
Mandy C Rainey
NPI 1144325887
$1,095.89
in general payments reported to CMS, 2019-2025
11 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $271 · 2022: $120 · 2023: $413 · 2024: $93.83 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $460.88 | 2022-2025 | Vemlidy |
| Inari Medical, INC. | $189.37 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Products, LP | $181.95 | 2021 | |
| Viiv Healthcare Company | $137.95 | 2021-2025 | Cabenuva, Dovato |
| Theratechnologies INC. | $32.07 | 2024 | Trogarzo, Egrifta |
| Boston Scientific Corporation | $24.76 | 2022 | |
| Philips North America LLC | $18.66 | 2025 | Lm Undivided |
| Napo Pharmaceuticals INC | $16.26 | 2021 | |
| Lilly USA, LLC | $13.26 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $11.79 | 2021 | |
| Janssen Biotech, INC. | $8.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Rainey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.